Forecast 2023-2028: Strong Growth Expected in Global Fetal Doppler Market Driven by Increased At-Home Utilization and Technological Advancements

The ResearchAndMarkets.com platform now includes the “Fetal Doppler Market – Global Outlook & Forecast 2023-2028” report in its offerings. The global fetal Doppler market is poised for significant advancement driven by heightened at-home usage, integration with mobile apps, and a…

Read MoreForecast 2023-2028: Strong Growth Expected in Global Fetal Doppler Market Driven by Increased At-Home Utilization and Technological Advancements

Viz.ai Corrects and Replaces Announcement: Viz™ Neuro Suite’s Impact on Patient Care Validated by Six Clinical Studies

The second sentence of the first paragraph of the release should read: “Six studies, presented at the International Stroke Conference (ISC) 2024, have shown positive outcomes with real-world impact of Viz.ai in clinical practice across various neurology pathologies including acute…

Read MoreViz.ai Corrects and Replaces Announcement: Viz™ Neuro Suite’s Impact on Patient Care Validated by Six Clinical Studies

Delta-Fly Pharma Inc. Submits Abstracts for Phase I Clinical Trial of DFP-14927 to the 2024 ASCO Annual Meeting

Following our previous update on January 5, 2024, we are delighted to share the latest advancements with you. A Phase I dose-ranging clinical trial investigating DFP-14927 in patients with solid tumors has been successfully conducted at MD Anderson Cancer Center…

Read MoreDelta-Fly Pharma Inc. Submits Abstracts for Phase I Clinical Trial of DFP-14927 to the 2024 ASCO Annual Meeting

Enanta Pharmaceuticals Announces Fiscal First Quarter Financial Results for December 31, 2023, Hosting Webcast and Conference Call Today at 4:30 p.m. ET

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology firm specializing in small molecule drugs within virology and immunology, has released its financial results for the fiscal first quarter ending December 31, 2023. The company’s President and Chief Executive Officer, Jay…

Read MoreEnanta Pharmaceuticals Announces Fiscal First Quarter Financial Results for December 31, 2023, Hosting Webcast and Conference Call Today at 4:30 p.m. ET

Healthmine Welcomes Maureen Sullivan, Former Executive at Blue Cross Blue Shield Association, to Advisory Board

Healthmine Welcomes Maureen Sullivan, Former Chief Strategy and Innovation Officer at Blue Cross Blue Shield Association, to Advisory Board Healthmine, a pioneer in technology-driven member engagement solutions, proudly announces the addition of Maureen Sullivan, President of Balestrand Strategic Advisors, to…

Read MoreHealthmine Welcomes Maureen Sullivan, Former Executive at Blue Cross Blue Shield Association, to Advisory Board

BGB Group Collaborates with Scrum50 to Provide Impactful, Consumer-Focused Creative Solutions to Healthcare Clients

BGB Group (BGB), a distinguished healthcare commercialization and communications firm headquartered in New York City with additional offices in Washington DC, Boston, and London, has revealed a strategic partnership with Scrum50 (S50). Scrum50, a dynamic and agile-first creative agency located…

Read MoreBGB Group Collaborates with Scrum50 to Provide Impactful, Consumer-Focused Creative Solutions to Healthcare Clients

US Demonstrates Clinical Effectiveness of FEops AI-Enhanced Predictive Pre-planning for Left Atrial Appendage Occlusion (LAAO)

Data from the inaugural US-wide single-center experience at St. Bernard’s Medical Center and Arrhythmia Research Group, presented at a Late-Breaking session during the AF Symposium 2024 in Boston, demonstrates that Left Atrial Appendage Occlusion (LAAO) procedures, strategically planned using FEops…

Read MoreUS Demonstrates Clinical Effectiveness of FEops AI-Enhanced Predictive Pre-planning for Left Atrial Appendage Occlusion (LAAO)

FDA Grants Approval to Edwards’ EVOQUE Valve Replacement System, Marking a Milestone as the First Transcatheter Therapy for Tricuspid Valve

Edwards Lifesciences Corporation (NYSE: EW) has announced the FDA approval of its EVOQUE tricuspid valve replacement system, marking a groundbreaking achievement as the first transcatheter therapy authorized for treating tricuspid regurgitation (TR) in the United States. The EVOQUE system is…

Read MoreFDA Grants Approval to Edwards’ EVOQUE Valve Replacement System, Marking a Milestone as the First Transcatheter Therapy for Tricuspid Valve

Revolutionizing Diagnostics and Advancing Life Sciences Innovation from Early-Phase Research to Clinical Applications: Revvity Unveils State-of-the-Art Solutions at SLAS2024

Unveiling the New Brand: Making its debut at SLAS, Revvity introduces its fresh brand, emphasizing the ongoing commitment to pushing the boundaries of human potential through scientific innovation. The revitalized company showcases a range of specialized technologies and expertise geared…

Read MoreRevolutionizing Diagnostics and Advancing Life Sciences Innovation from Early-Phase Research to Clinical Applications: Revvity Unveils State-of-the-Art Solutions at SLAS2024

SCIEX Enhances High-Throughput Screening Solutions through Introduction of Echo® MS+ System

SCIEX, a renowned global provider of analytical technologies in the life sciences, has unveiled the Echo® MS+ system during SLAS 2024. This cutting-edge system integrates the proprietary Acoustic Ejection Mass Spectrometry technology with Open Port Interface (OPI) sampling, leveraging the…

Read MoreSCIEX Enhances High-Throughput Screening Solutions through Introduction of Echo® MS+ System